SGLT-2 inhibitors reduce adverse CV events associated with restenosis in stents in patients with type 2 diabetes.

Published Date: 13 Mar 2023

Italy: Treatment with SGLT2 inhibitors in patients with type 2 diabetes (T2D) is associated with a reduced risk of restenosis in the stent...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Significant differences in breast cancer care still exist, but surgeons can change.

2.

More Data Back Teclistamab for Autoimmune Disease

3.

Study shows virtual reality headsets may help ease cancer pain

4.

Could CT scans be fueling a future rise in cancer cases, as a new study suggests?

5.

In R/R Follicular Lymphoma, Tisa-Cel Produces Long-Lasting Responses.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot